Brendon Neuen

Associate Professor Brendon Neuen

Associate Professor Brendon Neuen is a nephrologist, Director of Kidney Trials at Royal North Shore Hospital, and Program Lead, Renal and Metabolic Division at The George Institute for Global Health. He holds senior leadership roles in several international randomized trials evaluating novel therapeutic strategies to reduce kidney disease progression and cardiovascular risk. He co-chairs SMART-C (SGLT2 Meta‑Analysis Cardio‑Renal Trialists’ Consortium) and is Director of the CLARITY-IgAN Consortium (Collaborative Longitudinal Assessment of Randomised Interventions and Therapies in IgA Nephropathy). His research has informed more than 30 international clinical practice guidelines and scientific statements and has been featured in leading general medical journals, including the New England Journal of Medicine, Lancet, JAMA, and Nature Medicine.